TMPro mice exhibit a profoundly prometastatic phenotype relative to WT mice. Gross appearance of representative single lung lobes harvested from a WT (A) and TMPro mouse (B) 13 days after IV injection of 3 × 105 LLCGFP cells viewed under a fluorescence stereoscope. Note the overwhelming amount of GFP+ tumor tissue in the TMPro lung lobe in panel B relative to the WT animal in panel A. H&E stained sections of lung tissue revealed small, discreet metastatic foci (arrowhead) in lungs from WT mice (C), whereas lungs harvested from TMPro mice were largely effaced by tumor tissue (D). (E) Consistent with the apparent increase in tumor burden, the weight of lung tissue harvested from LLCGFP-challenged TMPro mice was significantly greater than that of lungs harvested from LLCGFP-challenged WT mice, or lungs from tumor-free animals. Similar findings were observed in cohorts of WT and TMPro mice intravenously injected in parallel with B16 melanoma cells. Shown are representative whole lungs from WT (F) and TMPro mice (G) as well as H&E-stained sections of lung tissue from WT (H) and TMPro mice (I). (J) Also paralleling results with LLC cells, the weight of lungs harvested from B16-challenged TMPro mice was significantly greater than that of lungs harvested from B16-challeged WT mice or tumor-free animals. Size bars represent 200 μm (C-D,H-I) or 250 mm (F-G). Data represents mean and SEM, *P < .005.